Mannkind Corp
NASDAQ: MNKD
$6.84
-$0.06 (-0.9%)
Closing Price on November 22, 2024
MNKD Articles
In Thursday morning’s trading session, it seemed almost across the board that biotech stocks were the largest gainers.
Published:
Among the most heavily shorted stocks traded on the Nasdaq between the November 28 and December 15 settlement dates, only Frontier Communications saw some rise in short interest.
Published:
The short interest data are out for the November 28 settlement date, and 24/7 Wall St. has reviewed the top biotech companies.
Published:
Among the most heavily shorted Nasdaq stocks between the November 14 and November 28 settlement dates, only BlackBerry saw a significant rise in short interest.
Published:
MannKind saw its shares trading lower on Thursday. The culprit may simply be insiders selling more shares.
Published:
ThinkstockThe short interest data are out for the November 14 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can make or...
Published:
Last Updated:
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies, such as Ebola-vaccine companies.
Published:
Surges in short interest in Intel and Comcast between the October 15 and October 31 settlement dates made sure they remained near the top of the list of most shorted Nasdaq stocks.
Published:
MannKind reported its third-quarter financial results on Monday morning.
Published:
Short interest in biotech leaders changed from directional to stock specific in the first two weeks of October.
Published:
Goldman Sachs has initiated on MannKind with a Neutral rating and a $6 price target, a move that may seem to some as the equivalent to a downgrade.
Published:
These are the top analyst upgrades and downgrades featured by 24/7 Wall St. for Monday, October 20, 2014.
Published:
The short interest data are out for the end of September settlement date, and 24/7 Wall St. has reviewed the top biotech companies.
Published:
While Apple was slipping down the list of the most shorted stocks on the Nasdaq, it passed Microsoft on the way up.
Published:
Short sellers are often active in biotech stocks, and we have seen some excessive short interest activity in the most recent report.
Published: